Bimatoprost: Medgend

Bimatoprost FDA Approved Drugs

BIMATOPROST [Bimatoprost^{C₂₅H₃₇NO₄}]

0.03% (topical solution/drops)

Apotex Inc^{Dec 1, 2014}
Lupin Ltd^{Feb 20, 2015}
Sandoz Inc^{Apr 19, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

LATISSE [Bimatoprost^{C₂₅H₃₇NO₄}]

0.03% (topical solution/drops)

Allergan^{Dec 24, 2008}

Method of increasing eyelash growth including length, thickness, darkness and/or number of eyelashes by administering bimatoprost to an eyelid margin.
Method of increasing eyelash growth with bimatoprost.
Method of increasing eyelash growth.
Method of increasing growth of hair including eyelashes.
Method of increasing hair growth.
Method of stimulating hair growth.
Treatment of hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

LUMIGAN [Bimatoprost^{C₂₅H₃₇NO₄}]

0.01% (ophthalmic solution/drops)

Allergan^{Aug 31, 2010}

A method of lowering intraocular pressure in a patient with open angle glaucoma or ocular hypertension.
A method of lowering intraocular pressure.
A method of reducing intraocular pressure in patients with open angle glaucoma or ocular hypertension.
A method of treating a patient with glaucoma or ocular hypertension.
Method of treating glaucoma in a patient.
Method of treating glaucoma or elevated intraocular pressure.
Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.